A machine learning and network framework to discover new indications for small molecules
C. Gilvary, J. Elkhader, N. Madhukar, C. Henchcliffe, M. Goncalves, O. Elemento
This paper introduces a machine learning framework, CATNIP, to predict novel drug indications using molecular features, identifying potential therapies for diseases like Parkinson's and Type 2 Diabetes.
bioRxiv · Aug 28, 2019Pharmacology & Toxicology